The objective of this study is to measure the change in blood values after the administration of an amino acid based erythropoietin stimulating system.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Prescription medical food erythropoietin stimulating system
Targeted Medical Pharma
Los Angeles, California, United States
Hemoglogin/Hematocrit
Time frame: 28 Days
Red blood cell count
Time frame: 28 Days
Reticulocyte count
Time frame: 28 days
IGF-1
Time frame: 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.